ALAM KAMRAN (Chief Financial Officer) received a stock award from TAYSHA GENE THERAPIES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/14/2026ACC: 0001793412-26-000002
Officer· Chief Financial Officer
Since Sep 2020
+590K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
590K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+359K
Price / share
—
Trade value
—
% of position
30.2%
1/12/2026
1.19M→1.55M
Total
Net shares
+359K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/12/2026 | A · Award | +359K | — | — | 30.2% | 1.19M | 1.55M |
| Total | +359K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
231K shares
Shares
+231K
Strike price
4.86
Held after
231K
Exercisable
—
1/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock231K shares | 1/12/2026 | A · Award | +231K | 4.86 | — | 231K |